Enlivex Therapeutics
ENLV
ENLV
8 hedge funds and large institutions have $7.52M invested in Enlivex Therapeutics in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
+1
Holders Change %
+14.29%
% of All Funds
0.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
DA
DSC Advisors
Chicago,
Illinois
|
-$547K |
| 2 |
PWP
Private Wealth Partners
Mill Valley,
California
|
-$86K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.71K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VAM
1
Visium Asset Management
New York
| $5.07M | – | – | – |
|
|
KCM
2
Knoll Capital Management
Miami,
Florida
| $2.03M | – | – | – |
|
|
OC
3
Oppenheimer & Co
New York
| $301K | +$203K | +847 | +208% |
|
|
SIM
4
Spark Investment Management
New York
| $104K | +$104K | +435 | New |
|
|
LTFS
5
Ladenburg Thalmann Financial Services
Miami,
Florida
| $6K | +$6K | +25 | New |
|
6
Wells Fargo
San Francisco,
California
| $5K | +$5K | +20 | New |
|
7
Morgan Stanley
New York
| $4K | +$3.78K | +17 | +1,700% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $3K | -$1.71K | -8 | -36% |
|
|
DA
9
DSC Advisors
Chicago,
Illinois
| – | -$547K | -2,142 | Closed |
|
|
PWP
10
Private Wealth Partners
Mill Valley,
California
| – | -$86K | -338 | Closed |
|